HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SCC President-Elect Discusses Year Ahead, Concerns About Naturals, Regs

This article was originally published in The Rose Sheet

Executive Summary

The Society of Organic Chemists is optimistic about the upcoming year, but in a recent interview President-elect Gary Agisim expressed concerns about several trends currently shaping the personal-care marketplace

You may also be interested in...



NPA Unveils First U.S. Standard For Natural Personal Care; Criteria Will Evolve

Products formulated with 95 percent "truly natural" ingredients that pose no suspected human health risks can apply to be certified "natural" under the Natural Products Association's newly released standard and certification program

Enginuity Data Management Lets Innovators Innovate, Avoid “Barrier Reefs”

Enginuity PLM's data management platform takes personal-care companies out of the age of Excel spreadsheets, electronically linking formulators past and present around the globe to streamline the product development process, negotiate regulatory obstacles, manage cost, and accelerate innovation, according to CEO John Sottery, Ph.D

REACH Pre-Registration Opens In June; Firms Advised To Begin Amassing Data

Although the first registration deadline for phase-in substances is not until 2010, companies subject to Registration, Evaluation, Authorization and Restriction of Chemicals law in Europe should start compiling relevant data now, speakers at an April 14 REACH workshop in Brussels, Belgium, said

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015427

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel